U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H30O3
Molecular Weight 318.4504
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXYMESTERONE

SMILES

[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CCC4=C(O)C(=O)CC[C@]34C

InChI

InChIKey=RXXBBHGCAXVBES-XMUHMHRVSA-N
InChI=1S/C20H30O3/c1-18-9-8-16(21)17(22)15(18)5-4-12-13(18)6-10-19(2)14(12)7-11-20(19,3)23/h12-14,22-23H,4-11H2,1-3H3/t12-,13+,14+,18-,19+,20+/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H30O3
Molecular Weight 318.4504
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Oxymestereone is anabolic-androgenic steroid, a methylated derivative of testosterone. The drug was developed in 1960 and was in clinical use under brand names Oranabol, Anamidol, Balnimax, Sanabol, and Theranabol, however, it was discontinued later.

Approval Year

Sample Use Guides

In Vivo Use Guide
In men, a common clinical dose for oxymesterone was 20-40 mg per day. In the athletic arena, an effective oral daily dosage also falls in the range of 20-40 mg, taken in cycles lasting no more than 6-8 weeks to minimize hepatotoxicity.
Route of Administration: Oral
Substance Class Chemical
Record UNII
4R73K9MRMX
Record Status Validated (UNII)
Record Version